Using magnets to release proteins for spinal cord injury recovery
Official title: Magnetically Triggered Protein Release for Varying Severities of Spinal Cord Injury
Funded at Rensselaer Polytechnic Institute · NIH-10984638 · Data updated 2026-11-12
This study is exploring a new way to help people recover from spinal cord injuries by using special fibers that can release healing substances when exposed to a magnetic field, making treatments more personalized and effective.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rensselaer Polytechnic Institute NIH-funded |
| Lab location | 1 site (Troy, United States) |
| Project start | August 3, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $151,559 |
| NIH project number | 1R03NS133674-01A1 |
| Project ID | NIH-10984638 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have experienced spinal cord injuries of varying severities.
✕Less likely to help
Patients with spinal cord injuries that are too severe or those who are not eligible for experimental treatments may not benefit from this research.
What this research studies
This research focuses on developing innovative drug delivery systems that use magnetically responsive fibers to enhance recovery after spinal cord injuries. By creating electrospun fibers loaded with growth factors, the team aims to control the release of these therapeutic agents in response to a magnetic field, allowing for tailored treatment based on individual patient needs. This approach addresses the variability in inflammation that occurs after spinal cord injuries, which can affect recovery outcomes. The goal is to improve regeneration of damaged spinal cord tissues and promote healing.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for spinal cord injuries, potentially improving recovery and quality of life for patients.
How similar studies have gone: Previous research has shown promise in using biomaterials for drug delivery in spinal cord injuries, but this specific approach using magnetic stimulation is relatively novel.
Where this research is happening
-
Rensselaer Polytechnic Institute
Troy, United States Active
Researchers
- Principal investigator: Gilbert, Ryan J. — Rensselaer Polytechnic Institute
- Study coordinator: Gilbert, Ryan J.
Related research
Other NIH-funded projects on the same topics.
-
Corticospinal neurons and recovery of precise forelimb movement after spinal cord injury
This project studies how spine injuries change brain circuits and whether targeted rehabilitation helps restore precise forelimb movement.
-
How baclofen and spinal cord stimulation interact in people with spinal cord injury
This study looks at how a common antispasmodic medicine (baclofen) works together with spinal cord stimulation in people who have spinal cord injuries and live with spasticity.
-
Targeting spinal cord inflammation with a new HuR inhibitor to help SCI patients
A new treatment approach uses a small molecule to block a brain-spinal inflammation regulator (HuR) that drives harmful inflammation after spinal cord injury, aiming to lessen damage and pain for people with SCI.
-
From Neural Control of Movement to Treatments for Spinal Cord Injury
A patient-focused project aims to translate how brain signals control movement after spinal cord injury into new treatments that improve muscle function and reduce spasticity.
-
Polaris: a compact system to help motor recovery after spinal cord injury and stroke
A new, easy-to-use device called Polaris may help people with spinal cord injury, stroke, or other chronic conditions regain movement by guiding a specialized reflex-based therapy.
-
Predicting and Preventing Chronic Aspiration After Traumatic Cervical Spinal Cord Injury
This project looks at swallowing problems and chronic aspiration in adults with traumatic neck spine injuries to find patterns that could prevent serious lung complications.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.